Egypt's Health Ministry on Thursday approved a new oral interferon-free hepatitis C drug, to be available at the national hepatitis treatment centers in the coming period.
In a statement on Thursday, AbbVie, the drug's manufacturer, said that "QUREVO" drug could yield 100% cure rate.
QUREVO is the first HCV infection treatment that has successfully demonstrated favorable safety and efficacy profiles, without necessitating co-administration with interferon.
The ministry gives high priority to the prevention and treatment of hepatitis.
According to the United Nations Population Fund, Egypt has the highest rate of hepatitis C infection in the world; 14.7 percent of the population between ages 15-49 have tested positive for the virus.
GMT 13:50 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 13:20 2018 Monday ,29 October
National campaign to raise awareness of breast cancerGMT 14:34 2018 Friday ,19 October
Birth spacing "improving health of Omani women"GMT 15:35 2018 Thursday ,11 October
Russia to discuss issue of biological labs near its bordersGMT 16:14 2018 Saturday ,29 September
Premier Khalifa bin Salman congratulated by health ministerGMT 16:10 2018 Saturday ,29 September
Bahrain to host Dermatology, Laser and Aesthetics ConferenceGMT 12:44 2018 Friday ,28 September
EU proposes €40 million for UNRWA to keep health clinics openGMT 07:46 2018 Wednesday ,26 September
HRH Premier to address UN high-level health meetingsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor